Label: VENTIPULMIN- clenbuterol syrup

  • NDC Code(s): 0010-3017-02, 0010-3017-03
  • Packager: Boehringer Ingelheim Vetmedica, Inc.
  • Category: PRESCRIPTION ANIMAL DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Animal Drug Application

Drug Label Information

Updated December 8, 2017

If you are a consumer or patient please visit this version.

  • SPL UNCLASSIFIED SECTION

    NADA 140-973, Approved by FDA

    For oral use in horses only

    Close
  • Caution:

    Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Close
  • Caution:

    Federal law prohibits the extralabel use of this drug in food animals.

    Close
  • Each mL contains:

    Clenbuterol HCl 72.5 mcg

    Close
  • Description:

    Clenbuterol (4-amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol hydrochloride) is a beta-2-adrenergic agonist which provides bronchodilating properties as well as other effects, with minimum effect on the cardiovascular system. It is provided as a colorless, palatable syrup. Ventipulmin Syrup (clenbuterol hydrochloride) is antagonized by beta-adrenergic blocking agents.

    Close
  • Indications:

    Ventipulmin Syrup (clenbuterol hydrochloride) is indicated for the management of horses affected with airway obstruction, such as occurs in chronic obstructive pulmonary disease (COPD).

    Close
  • Contraindications:

    Ventipulmin Syrup antagonizes the effects of prostaglandin F2 alpha and oxytocin. Ventipulmin Syrup should not be used in pregnant mares near term. Because tachycardia may occur, Ventipulmin Syrup should not be used in horses suspected of having cardiovascular impairment.

    Close
  • Warning:

    The effect on reproduction in breeding stallions and brood mares has not been determined. Treatment starting with dosages higher than the initial dose is not recommended.

    Close
  • Human Warnings:

    Not for human use. Do not use in horses intended for human consumption. Keep out of the reach of children. In case of accidental ingestion, contact a physician immediately. Ingestion of Ventipulmin Syrup may cause undesirable reactions. Clenbuterol, like other beta adrenergic agonists, can produce significant cardiovascular effects in some people as evidenced by elevated pulse rate, blood pressure changes and/or ECG changes.

    Close
  • Dosage and Administration:

    Administer orally twice a day (b.i.d.). Initial dose is 0.5 mL/100 lbs body weight (0.8 mcg/kg) twice daily.

    Close
  • Dosage Schedule:

    Initial dosage: administer 0.5 mL/100 lbs (0.8 mcg/kg) for 3 days (6 treatments);

    If no improvement, administer 1.0 mL/100 lbs (1.6 mcg/kg) for 3 days (6 treatments);

    If no improvement, administer 1.5 mL/100 lbs (2.4 mcg/kg) for 3 days (6 treatments);

    If no improvement, administer 2.0 mL/100 lbs (3.2 mcg/kg) for 3 days (6 treatments);

    If no improvement, horse is non-responsive to clenbuterol and treatment should be discontinued.

    Recommended duration of treatment at effective dose is 30 days. At the end of this 30-day treatment period, drug should be withdrawn to determine recurrence of signs. If signs return, the 30-day treatment regimen may be repeated. If repeating treatment, the step-wise dosage schedule should be repeated.

    Close
  • Directions for Administration:

    Remove safety cap and seal; replace with enclosed plastic dispensing cap. Remove cover from dispensing tip and connect syringe (without needle). Draw out appropriate volume of Ventipulmin Syrup. Administer orally to the horse. Replace cover on dispensing tip to prevent leakage.

    Close
  • Dosage Calculation Chart

    Lbs. Body

    Weight

    mL/treatment

    at 0.5 mL/100#

    (0.8 mcg/kg)

    mL/treatment

    at 1.0 mL/100#

    (1.6 mcg/kg)

    mL/treatment

    at 1.5 mL/100#

    (2.4 mcg/kg)

    mL/treatment

    at 2.0 mL/100#

    (3.2 mcg/kg)

    500

    600

    700

    800

    900

    1000

    1100

    1200

    1300

    1400

    1500

    1600

    1700

    1800

    2.5

    3.0

    3.5

    4.0

    4.5

    5.0

    5.5

    6.0

    6.5

    7.0

    7.5

    8.0

    8.5

    9.0

    5.0

    6.0

    7.0

    8.0

    9.0

    10.0

    11.0

    12.0

    13.0

    14.0

    15.0

    16.0

    17.0

    18.0

    7.5

    9.0

    10.5

    12.0

    13.5

    15.0

    16.5

    18.0

    19.5

    21.0

    22.5

    24.0

    25.5

    27.0

    10.0

    12.0

    14.0

    16.0

    18.0

    20.0

    22.0

    24.0

    26.0

    28.0

    30.0

    32.0

    34.0

    36.0

    Administer two treatments per day.

    Close
  • Precaution:

    The safety cap should be placed on the bottle when not in use.

    Close
  • Adverse Reactions:

    Mild sweating, muscle tremor, restlessness, urticaria and tachycardia may be observed in some horses during the first few days of treatment. May cause elevated creatine kinase (CK) serum levels. Ataxia was observed in 3 out of 239 horses (1.3%) in clinical studies. To report suspected adverse reactions, to obtain a Material Safety Data Sheet (MSDS), or for technical assistance, call 1-866-638-2226.

    Close
  • How Supplied:

    Ventipulmin Syrup is available in 100 mL and 330 mL plastic bottles containing 72.5 mcg clenbuterol HCl per mL.

    NDC 0010-3017-02 - 100 mL
    NDC 0010-3017-03 - 330 mL

    Close
  • Storage:

    Store at or below 25°C (77°F). Avoid freezing.

    Close
  • SPL UNCLASSIFIED SECTION

    Ventipulmin is a registered trademark of Boehringer Ingelheim Vetmedica GmbH.

    Manufactured for:
    Boehringer Ingelheim Vetmedica, Inc.
    St. Joseph, MO 64506 U.S.A.

    301704-05

    090330771/2

    Close
  • Principal Display Panel – 330 mL Container Label

    NDC 0010-3017-03

    Ventipulmin® Syrup

    Clenbuterol HCl 72.5 mcg/mL

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Caution: Federal law prohibits the extralabel use of this drug in food animals.

    For oral use in horses only

    Net Contents: 330 mL

    NADA 140-973, Approved by FDA

    Picture of 330 mL container label.
    Close
  • Principal Display Panel – 330 mL Display Carton – Front and Side Panel

    NDC 0010-3017-03

    Ventipulmin® Syrup

    Clenbuterol HCl 72.5 mcg/mL

    Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

    Caution: Federal law prohibits the extralabel use of this drug in food animals.

    For oral use in horses only

    Net Contents: 330 mL

    NADA 140-973, Approved by FDA

    Picture of the front and side of the 330 mL display carton.
    Close
  • Principal Display Panel - 330 mL Display Carton – Back and Side Panel
  • INGREDIENTS AND APPEARANCE
    VENTIPULMIN 
    clenbuterol syrup
    Product Information
    Product Type PRESCRIPTION ANIMAL DRUG Item Code (Source) NDC:0010-3017
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    CLENBUTEROL HYDROCHLORIDE (UNII: GOR5747GWU) (CLENBUTEROL - UNII:XTZ6AXU7KN) CLENBUTEROL HYDROCHLORIDE 0.0725 mg  in 1 mL
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:0010-3017-02 1 in 1 CARTON
    1 100 mL in 1 BOTTLE, PLASTIC
    2 NDC:0010-3017-03 1 in 1 CARTON
    2 330 mL in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    NADA NADA140973 01/12/2011
    Labeler - Boehringer Ingelheim Vetmedica, Inc. (007134091)
    Registrant - Boehringer Ingelheim Vetmedica, Inc. (007134091)
    Close